<DOC>
	<DOC>NCT01510522</DOC>
	<brief_summary>This is an open-label, multicenter, two-arm, parallel, randomized phase 4 study to compare the compliance in diabetes type 2 patients treated with Glucophage sachets versus patients treated with Glucophage tablets.</brief_summary>
	<brief_title>Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Diabetes mellitus type 2 diagnosed (Baseline Glycemia &gt; 7,0 mmol/L (126 mg/dL) or overload Glycemia &gt; 11,0 mmol/L (198 mg/dL) On treatment with metformin tablets Patients with at least 2 treated comorbidities Established dose of Metformin &gt; 1.700 mg/day Age &gt; 18 years old Given informed consent Patients not able to take medication orally According to Summary of Product Characteristics (SmPC) Participating in another clinical trial 30 days prior to randomization Any other illness or medical or psychiatric condition, severe and uncontrolled that could interfere in the patient's participation or in the assessment of the study results</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Glucophage</keyword>
	<keyword>Metformin</keyword>
	<keyword>sachets</keyword>
	<keyword>tablets</keyword>
</DOC>